Effectiveness of delayed use of crotalidae polyvalent immune fab (ovine) antivenom

Journal of Toxicology - Clinical Toxicology

Volumn 42, Issue 3, 2004, Pages 321-324

  Bebarta, Vikhyat ^a   Dart, Richard C ^a  

^a ROCKY MOUNTAIN POISON AND DRUG CENTER   (United States)

Author keywords

Antivenom; Crotalidae polyvalent immune fab (ovine); Envenomation; FabAV

Indexed keywords

IMMUNOGLOBULIN F(AB) FRAGMENT; SNAKE VENOM; VENOM ANTISERUM;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CASE REPORT; CONTROLLED STUDY; DRUG MANUFACTURE; ENVENOMATION; HUMAN; IMMUNE RESPONSE; MALE; PUBLICATION; RETROSPECTIVE STUDY; SNAKEBITE; SYMPTOMATOLOGY; UNITED STATES;

ANIMALS; ANTIVENINS; CROTALID VENOMS; CROTALUS; FIBRIN; FIBRINOGEN; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; SHEEP; SNAKE BITES; SUICIDE, ATTEMPTED; TIME FACTORS;

EQUUS CABALLUS; OVIS; SERPENTES;

EID: 4444368375     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-120037454     Document Type: Article

References (17)

1. Langley RL, Morrow WE. Deaths resulting from animal attacks in the United States. Wilderness Environ Med 1997; 8(1):8-16.
2. Gold BS, Dart RC, Barish RA. Bites of venomous snakes. N Engl J Med 2002; 347(5):347-356.
3. Dart RC, Seifert SA, Boyer LV, Clark RF, Hall E, McKinney P, McNally J, Kitchens CS, Curry SC, Bogdan GM, Ward SB, Porter RS. A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med 2001; 161(16):2030-2036.
4. Dart RC, Seifert SA, Carroll L, Clark RF, Hall E, Boyer-Hassen LV, Curry SC, Kitchens CS, Garcia RA. Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning. Ann Emerg Med 1997; 30(1):33-39.
5. Clark RF, McKinney PE, Chase PB, Walter FG. Immediate and delayed allergic reactions to Crotalidae polyvalent immune Fab (ovine) antivenom. Ann Emerg Med 2002; 39(6):671-676.
6. Ruha AM, Curry SC, Beuhler M, Katz K, Brooks DE, Graeme KA, Wallace K, Gerkin R, Lovecchio F, Wax P, Selden B. Initial postmarketing experience with crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation. Ann Emerg Med 2002; 39(6):609-615.
7. Holstege CP, Wu J, Baer AB. Immediate hypersensitivity reaction associated with the rapid infusion of Crotalidae polyvalent immune Fab (ovine). Ann Emerg Med 2002; 39(6):677-679.
8. Bush SP, Green SM, Moynihan JA, Hayes WK, Cardwell MD. Crotalidae polyvalent immune Fab (ovine) antivenom is efficacious for envenomations by Southern Pacific rattlesnakes (Crotalus helleri). Ann Emerg Med 2002; 40(6):619-624.
9. Offerman SR, Bush SP, Moynihan JA, Clark RF. Crotaline Fab antivenom for the treatment of children with rattlesnake envenomation. Pediatrics 2002; 110(5):968-971.
10. CroFab, Crotalidae Polyvalent Immune Fab Ovine. Nashville, TN: Protherics, Inc., 2000. [package insert].
11. Dart RC, McNally J. Efficacy, safety, and use of snake antivenoms in the United States. Ann Emerg Med 2001; 37(2):181-188.
12. Yip L. Rational use of crotalidae polyvalent immune Fab (ovine) in the management of crotaline bite. Ann Emerg Med 2002; 39(6):648-650.
13. Bogdan GM, Dart RC, Falbo SC, McNally J, Spaite D. Recurrent coagulopathy after antivenom treatment of crotalid snakebite. South Med J 2000; 93(6):562-566.
14. Dart RC. Sequelae of pit envenomations. In: Campbell JA, Brodie ED, eds. Biology of Pit Vipers. Tyler, TX: Selva Publishing, 1992:395-404.
15. Boyer LV, Seifert SA, Cain JS. Recurrence phenomena after immunoglobulin therapy for snake envenomations: part 2. Guidelines for clinical management with crotaline Fab antivenom. Ann Emerg Med 2001; 37(2):196-201.
16. Rosen PB, Leiva JI, Ross PR. Delayed antivenom treatment for a patient after envenomation by Crotalus atrox. Ann Emerg Med 2000; 35(1):86-88.
17. Guisto JA. Severe toxicity from crotalid envenomation after early resolution of symptoms. Ann Emerg Med 1995; 26(3):387-389.